Immune modulation using mistletoe (Viscum album L.) extracts Iscador: Influencing cell function through subcutaneous and intravenous application

Arzneimittel-Forschung/Drug Research

Volumn 56, Issue 6 A, 2006, Pages 508-515

  Büssing, Arndt ^a,b  

^a Immunological Laboratory   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Granulocytes; Iscador ; Lymphocytes; Mistletoe extract, application route, immunomodulation; Viscum album L.

Indexed keywords

HLA DR ANTIGEN; VISCUM ALBUM EXTRACT; ANTINEOPLASTIC AGENT; IMMUNOLOGIC FACTOR; PLANT EXTRACT; VEGETABLE PROTEIN; VISCUM ALBUM PEPTIDE;

APPLE; ARTICLE; BREAST CANCER; DRUG EFFECT; GRANULOCYTE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; OAK; T LYMPHOCYTE; ANIMAL; ANTIBODY PRODUCTION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBODY FORMATION; ANTINEOPLASTIC AGENTS, PHYTOGENIC; GRANULOCYTES; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSION; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; PLANT EXTRACTS; PLANT PROTEINS;

EID: 33748663282     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296818     Document Type: Article

References (74)

1. Janssen, O., Scheffler, A., Kabelitz, D., In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis). Arzneim.-Forsch./Drug Res. 43, 1221 (1993)
2. Büssing, A. et al., Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Lett. 99, 59 (1996)
3. Büssing, A., Suzart, K., Schweizer, K., Differences in the apoptosis-inducing properties of Viscum album L. extracts. Anticancer Drugs 8 (Suppl. 1), S9 (1997)
4. Büssing, A., Multani, A. S., Pathak, S. et al., Induction of apoptosis by the N-acetyl-galactosamine-specific toxic lectin from Viscum album L. is associated with a decrease of nuclear p53 and Bcl-2 proteins and induction of telomeric associations. Cancer Lett. 130, 57 (1998)
5. Büssing, A. et al., Induction of mitochondrial Apo2.7 molecules and generation of reactive oxygen-intermediates in cultured lymphocytes by the toxic proteins from Viscum album L. Cancer Lett. 139, 79 (1999)
6. Büssing, A. et al., Expression of mitochondrial Apo2.7 molecules and caspase-3 activation in human lymphocytes treated with the ribosome-inhibiting mistletoe lectins and the cell membrane permeabilizing viscotoxins. Cytometry 37, 133 (1999)
7. Büssing, A., Stein, G. M., Herterich-Akinpelu, I. et al., Apoptosis-associated generation of reactive oxygen intermediates and release of pro-inflammatory cytokines in human lymphocytes and granulocytes by extracts from the seeds of Acalypha wilkesiana. J. Ethnopharmacol. 66, 301 (1999)
8. Büssing, A. et al., Accidental cell death and generation of reactive oxygen intermediates in human lymphocytes induced by thionins from Viscum album L. Eur. J. Biochem. 262, 79 (1999)
9. Büssing, A., Stein, G. M., Selective killing of CD8+ cells with a 'memory' phenotype (CD62Llo) by the N-acetyl-D-galactosamine-specific lectin from Viscum album L. Cell Death Differ. 5, 231 (1998)
10. Büssing, A., Schaller, G., Pfüller, U., Generation of reactive oxygen intermediates (ROI) by the thionins from Viscum album L. Anticancer Res. 18, 4291 (1998)
11. Büssing, A., Mistletoe. The Genus Viscum. Medicinal an Aromatic plants - Industrial Profiles. Harwood Academic Publishers, Amsterdam (2000)
12. Berg, P. A., Stein, G. M., Beeinflusst die Misteltherapie die Abwehr epithelialer Tumoren? Eine kritische immunologische Analyse. Dtsch. Med. Wochenschr. 126, 339 (2001)
13. Kienle, G. S., Kiene, H., Die Mistel in der Onkologie. Fakten und konzeptionelle Grundlagen. Schattauer, Stuttgart - New York (2003)
14. Zschiesche, W., Die Wirkung von Iscador auf die Phagozytoseaktivität des reticulohistiozytären Systems. Monatsber. Dtsch. Akad. Wiss. 8, 750 (1966)
15. |15) Bloksma, N., Schmiermann, P., de Reuver, M. et al., Stimulation of humoral and cellular immunity by Viscum preparations. Planta Med. 4, 221 (1982)
16. Nienhaus, J., Leroi, R., Tumorhemmung und Thymus-stimulation durch Mistelpräparate. Elemente Natw. 13, 45 (1970)
17. Bloksma, N., van Dijk, H., Korst, P. et al., Cellular and humoral adjuvant activity of a mistletoe extract. Immunobiology 156, 309 (1979)
18. Khwaja, T. A., Dias, C. B., Papoian, T. et al., Studies on cytotoxic and immunologic effects of Viscum album (mistletoe). Proc. Am. Ass. Cancer Res. 22, 253 (1980)
19. Bloksma, N., Schmiermann, P., de Reuver, M. et al., Stimulation of humoral and cellular immunity by Viscum preparations. Planta Med. 4, 221 (1982)
20. |20] Hajto, T., Immunomodulatory effects of Iscador: a Viscum album preparation. Oncology 43 (Suppl. 1), 51 (1986)
21. Hajto, T, Hostanska, K., Gabius, H. J., Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res. 49, 4803 (1989)
22. Hajto, T, Hostanska, K., Fischer, J. et al., Investigations of cellular parameters to establish the response of a biomodulator: galactoside-specific lectin from Viscum album plant extract. Phytomedicine. 3, 129 (1996)
23. Beuth, J., Ko, H. L., Gabius, H. J. et al., Influence of treatment with the immunomodulatory effective dose of betagalactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model systems. In Vivo 5, 29 (1991)
24. Beuth, J. et al., Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1. In Vivo 7, 407 (1993)
25. Beuth, J. et al., Immunaktive Wirkung von Mistellektin-1 in Abhängigkeit von der Dosierung. Arzneim.-Forsch./Drug Res. 44, 1255 (1994)
26. Beuth, J., Stoffel, B., Ko, H. L. et al., Immunomodulating ability of galactoside-specific lectin standardized and depleted mistletoe extract. Arzneim.-Forsch./Drug Res. 45, 1240 (1995)
27. Beuth, J. et al., Modulating activity of mistletoe lectins 1 and 2 on the lymphatic system in BALB/c mice. Phytmedicine 2, 239 (1996)
28. Stoffel, B., Krämer, K., Mayer, H. et al., Immunomodulating efficacy of combined administration of galactose-specific lectin standardized mistletoe extract and sodium selenite in BALB/c-mice. Anticancer Res. 17, 1893 (1997)
29. Fischer, S., Scheffler, A., Kabelitz, D., Stimulation of the specific immune system by mistletoe extracts. Anticancer Drugs 8 (Suppl. 1), S33 (1997)
30. Fischer, S., Scheffler, A., Kabelitz, D., Oligoclonal in vitro response of CD4 T cells to vesicles of mistletoe extracts in mistletoe treated cancer patients. Cancer Immunol. Immunother. 44, 150 (1997)
31. Stein, G. M., Berg, P. A., Modulation of cellular and humoral immune responses of tumor patients by mistletoe therapy. Eur. J. Med. Res. 3, 194 (1998)
32. Stein, G. M., Berg, P. A., Modulation of cellular and humoral immune responses of tumor patients by mistletoe therapy. Eur. J. Med. Res. 3, 194 (1998)
33. Stein, G. M., Berg, P. A., Modulation of cellular and humoral immune responses during exposure of healthy individuals to an aqueous mistletoe extract. Eur. J. Med. Res. 3, 307 (1998)
34. Stein, G. M., Henn, W., von Laue, B. et al., Modulation of the cellular and humoral immune responses of tumour patients during mistletoe therapy. Eur. J. Med. Res. 3, 194 (1998)
35. Stein, G. M., Berg, P. A., Modulation of cellular and humoral immune responses of tumor patients by mistletoe therapy. Eur. J. Med. Res. 3, 194 (1998)
36. Fischer, S., Scheffler, A., Kabelitz, D., Stimulation of the specific immune system by mistletoe extracts. Anticancer Drugs 8 (Suppl. 1), S33 (1997)
37. Gorter, R. W., val Wely, M., Stoss, M. et al., Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador). Am. J. Ther. 5, 181 (1998)
38. Böcher, E., Stumpf, C., Büssing, A. et al., Prospektive Bewertung der To xizität hochdosierter Viscum album L.-Infusionen bei Patienten mit progredienten Malignomen. Z. Onkol. 28, 97 (1996)
39. Bussing, A., Stumpf, C., Wutte, H. et al., Therapiebegleitende Untersuchung immunologischer Parameter bei Tumor-Patienten nach hochdosierter intravenöser Applikation von Viscum album L.-Extrakten. Zschr. Onkol. 28, 54 (1996)
40. Stein, G. M., Stettin, A., Schultze, J. et al., Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts. Anticancer Drugs 8 (Suppl. 1), S57 (1997)
41. Stein, G. M., Berg, P. A., Modulation of the cellular and humoral immune responses during mistletoe treatment in healthy individuals. Eur. J. Med. Res. 3, 307 (1998)
42. Stettin, A., Schultze, J. L., Stechemesser, E. et al., Anti-Mistletoe Lectin Antibodies Are Produced in Patients During Therapy with Aqueous Mistletoe Extract Derived from Viscum album L. and Neutralize Lectin-Induced Cytotoxicity in Vitro. Klin. Wochenschr. 68, 896 (1990)
43. Ribéreau-Gayon, G., Jung, M. L., Beck, J. P. et al., Effect of fetal calf serum on the cytotoxic activity of mistletoe (Viscum album L.) lectins in cell culture. Phytother. Res. 9, 336 (1995)
44. Ribéreau-Gayon, G., Jung, M. L., Frantz, M. et al., Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins. Anticancer Drugs 8 (Suppl. 1), S3 (1997)
45. Salzer, G., Pleura Carcinosis. Cytomorphological findings with the mistletoe preparation Iscador and other pharmaceuticals. Oncology 43, 66 (1986)
46. Salzer, G., Popp, W, Die lokale Iscadorbehandlung der Pleurakarzinose in Krebs und Alternativmedizin II, Jungi & Senn (eds.), pp. 70-83, Springer Verlag, Heidelberg (1990)
47. Stumpf, C., Schietzel, M., Intrapleurale Instillation eines Extraktes aus Viscum album [L.] zur Behandlung maligner Pleuraergüsse. Tumordiagn. Ther. 15, 57 (1994)
48. Stumpf, C., Büssing, A., Stimulation of antitumour immunity by intrapleural instillation of a Viscum album L. extract. Anticancer Drugs 8 (Suppl. 1), S23 (1997)
49. Scheffler, A., Mast, H., Fischer, S. et al., Komplette Remission eines Mundhöhlenkarzinoms nach alleiniger Mistelbehandlung. In: Grundlagen der Misteltherapie. Akueller Stand der Forschung und klinische Anwendung. Scheer, R., Becker, H., Berg, P. A. (eds.), pp. 453-464, Hippokrates Verlag, Stuttgart (1996)
50. Stumpf, C., Ramirez-Martinez, S., Becher, A. et al., Intratumorale Mistelapplikation bei stenosierendem Rezidiv eines Cardia-Carcinoms. Erfahrungsheilkunde, Sonderausgabe August, 509-513 (1997)
51. Stein, G. M., Meink, H., Durst, J. et al., Release of cytokines by a fermented lectin-1 (ML-1) free mistletoe extract reflects differences in the reactivity of PBMC in healthy and allergic individuals and tumour patients. Eur. J. Clin. Pharmacol. 51, 247 (1996)
52. Stein, G. M., Berg, P. A., Flow cytometric analyses of the specific activation of peripheral blood mononuclear cells from healthy donors after in vitro stimulation with a fermented mistletoe extract and mistletoe lectins. Eur. J. Cancer 34, 1105 (1998)
53. Stein, G. M., Berg, P. A., Modulation of cellular and humoral immune responses during exposure of healthy individuals to an aqueous mistletoe extract. Eur. J. Med. Res. 3, 307 (1998)
54. Stein, G. M., Berg, P. A., Modulation of cellular and humoral immune responses of tumor patients by mistletoe therapy. Eur. J. Med. Res. 3, 194 (1998)
55. Stein, G. M., Berg, P. A., Modulation of cellular and humoral immune responses of tumor patients by mistletoe therapy. Eur. J. Med. Res. 3, 194 (1998)
56. Stein, G. M., Berg, P. A., Modulation of cellular and humoral immune responses of tumor patients by mistletoe therapy. Eur. J. Med. Res. 3, 194 (1998)
57. Stein, G. M., Stettin, A., Schultze, J. et al., Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts. Anticancer Drugs 8 (Suppl. 1), S57 (1997)
58. Stein, G. M., Berg, P. A., Modulation of cellular and humoral immune responses of tumor patients by mistletoe therapy. Eur. J. Med. Res. 3, 194 (1998)
59. Beuth, J. et al., Behaviour of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients. Clin. Invest. 70, 658 (1992)
60. Beuth, J., Ko, H. L., Tunggal, L. et al., Vergleichende Untersuchungen zur immunaktiven Wirkung von Galaktosid-spezifischem Mistellektin. Reinsubstanz gegen standardisierten Extrakt. Arzneim.-Forsch./Drug Res. 43, 166 (1993)
61. Heiny, B. M., Beuth, J., Misteltoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients. Anticancer Res. 14, 1339 (1994)
62. Bussing, A., Rosenberger, A., Stumpf, C. et al., Development of lymphocyte subsets in tumor patients after subcutaneous administration of mistletoe extracts. Forsch. Komplementärmed. Klass. Naturheilkd. 6, 196 (1999)
63. Stein, G. M., Pfüller, U., Schietzel, M., Viscotoxin-free aqueous extracts from European mistletoe (Viscum album L.) stimulate activity of human granulocytes. Anticancer Res. 19, 2925 (1999)
64. Stein, G. M., Pfüller, U. Schietzel, M., Viscotoxin-free aqueous extracts from Viscum album L. stimulate activity of human granulocytes. Anticancer Res. 19, 2925 (1999)
65. Stein, G. M., Schaller, G., Pfüller, U. et al., Thionins from Viscum album L.: influence of the viscotoxins on the activation of granulocytes. Anticancer Res. 19, 1037 (1999)
66. Büssing, A. et al., Prevention of surgery-induced depression of granulocyte function by intravenous application of a fermented extract from Viscum album L. in breast cancer patients. Anticancer Res. 25, 4753 (2005)
67. Ogawa, M. et al., Suppression of cellular immunity by surgical stress. Surgery 127, 329 (2000)
68. Büssing, A. et al., Beeinflussung der Granulozytenfuktion durch einmalige perioperative Mistelextrakt-Infusion. Dtsch. Zschr. Onkol. 36, 148 (2004)
69. Bussing, A., Azhari, T., Ostendorp, H. et al., Viscum album L. extracts reduce sister chromatid exchanges in cultured peripheral blood mononuclear cells. Eur. J. Cancer 30A, 1836 (1994)
70. Bussing, A., Lehnert, A., Schink, M. et al., Effect of Viscum album L. on rapidly proliferating amniotic fluid cells. Sister chromatid exchange frequency and proliferation index. Arzneim.-Forsch./Drug Res. 45, 81 (1995)
71. Bussing, A., Regnery, A., Schweizer, K., Effects of Viscum album L. on cyclophosphamide-treated peripheral blood mononuclear cells in vitro: sister chromatid exchanges and activation/proliferation marker expression. Cancer Lett. 94, 199 (1995)
72. Bussing, A., Jungmann, H., Suzart, K. et al., Suppression of sister chromatid exchange-inducing DNA lesions in cultured peripheral blood mononuclear cells by Viscum album L. J. Exp. Clin. Cancer Res. 15, 107 (1996)
73. Hajto, T., Lanzrein, C., Natural killer and antibody-dependent cell-mediated cytotoxicity activities and large granular lymphocyte frequencies in Viscum album-treated breast cancer patients. Oncology 43, 93 (1986)
74. Cazacu, M. et al., The influence of isorel on the advanced colorectal cancer. Cancer Biother. Radiopharm. 18, 27 (2003)